Cargando…
Multiscale Kinetic Modeling of Liposomal Doxorubicin Delivery Quantifies the Role of Tumor and Drug-Specific Parameters in Local Delivery to Tumors
Nanoparticle encapsulation has been used as a means to manipulate the pharmacokinetic (PK) and safety profile of drugs in oncology. Using pegylated liposomal doxorubicin (PLD) vs. conventional doxorubicin as a model system, we developed and experimentally validated a multiscale computational model o...
Autores principales: | Hendriks, B S, Reynolds, J G, Klinz, S G, Geretti, E, Lee, H, Leonard, S C, Gaddy, D F, Espelin, C W, Nielsen, U B, Wickham, T J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600732/ https://www.ncbi.nlm.nih.gov/pubmed/23835797 http://dx.doi.org/10.1038/psp.2012.16 |
Ejemplares similares
-
Companion Diagnostic (64)Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines
por: Lee, Helen, et al.
Publicado: (2018) -
Whole-body organ-level and kidney micro-dosimetric evaluations of (64)Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin ((64)Cu-MM-302) in rodents and primates
por: Gaddy, Daniel F, et al.
Publicado: (2015) -
Review of the Delivery Kinetics of Thermosensitive Liposomes
por: Haemmerich, Dieter, et al.
Publicado: (2023) -
Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou, Xiaoju, et al.
Publicado: (2012) -
Reversible Electroporation–Mediated Liposomal Doxorubicin Delivery to Tumors Can Be Monitored With (89)Zr-Labeled Reporter Nanoparticles
por: Srimathveeravalli, Govindarajan, et al.
Publicado: (2018)